Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-23-007624
Filing Date
2023-11-03
Accepted
2023-11-03 16:30:47
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 sonoma_s3.htm S-3 253339
2 FORM OF INDENTURE sonoma_ex0403.htm EX-4.3 313948
3 OPINION OF BURNS & LEVINSON, LLP sonoma_ex0501.htm EX-5.1 27944
4 CONSENT sonoma_ex2301.htm EX-23.1 2227
5 CALCULATION OF FILING FEE TABLE sonoma_ex107.htm EX-FILING FEES 28193
6 GRAPHIC image_003.jpg GRAPHIC 6740
7 GRAPHIC image_004.jpg GRAPHIC 5793
8 GRAPHIC image_005.jpg GRAPHIC 2881
  Complete submission text file 0001683168-23-007624.txt   648368
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-3 | Act: 33 | File No.: 333-275311 | Film No.: 231376830
SIC: 2834 Pharmaceutical Preparations